Spark Therapeutics is a publicly-traded, late clinical-stage gene therapy company with more than 700 employees. It researches medical treatments that can provide long-lasting effects that dramatically and positively change patients’ lives. Its treatments are for patients with conditions that have no, or only palliative, therapy available. The company has experienced significant growth requiring expansion and renovation of the existing facilities.
Watchdog was engaged for ongoing program management services as well as project management services for a relocation project. The team served as an extension of Spark’s in-house corporate facilities during a time of unprecedented growth. For the initial corporate office relocation engagement, Watchdog served as the Owner’s Representative. The team coordinated engineering and design reviews, provided oversight of the construction manager, evaluated the budget, and developed the project schedule.Read the whole story